Canopy Growth Q4 Results – Hubris Trumps Transparency Scott Willis·June 27, 2018Canopy's revenue missed estimates for the 7th quarter in a row, cash burn increased and transparency decreased. Analysis...Marijuana Analysis·1 Comment·
Top 10 Reasons Not to Invest in Marijuana Stocks… Yet Scott Willis·June 20, 2018Owning marijuana stocks could be a path to stock market riches, but these 10 hurdles must be overcome...Marijuana Analysis·5 Comments·
Marijuana Management: Who Can You Trust? Scott Willis·May 25, 2018Final 4 - Marijuana companies management compared. In a new, fast moving industry like marijuana, picking a management...Marijuana Analysis·15 Comments·
Marijuana News: Weekly Investor Report for May 18th Scott Willis·May 20, 2018Marijuana news for the week: Deal frenzy in Canada, Namaste's "The Pledge" signals marijuana stock bubble. Colombia is...Marijuana News·3 Comments·
Marijuana Scouts Honour: I Shall Not Sell My Namaste Shares Scott Willis·May 18, 2018Marijuana company Namaste Technologies asked investors to hold their shares for 90 days in exchange for attending a...Marijuana Analysis·5 Comments·
Why Aurora Overpaid for MedReleaf Scott Willis·May 14, 2018Aurora Cannabis Inc. (TSE:ACB) agreed to buy MedReleaf (TSE:LEAF) for CAD$3 billion, overpaying again for competitor capacity. Deal...Marijuana Analysis·1 Comment·
Marijuana News: Weekly Investor Report (May 11th) Scott Willis·May 12, 2018Marijuana news for the week: Global and Canadian marijuana stocks up; LPs exploring ways to get around labeling...Marijuana News·1 Comment·
Bay Street Gone Wild: Why Marijuana Stocks are Overvalued Scott Willis·May 8, 2018Bay Street is overly optimistic on the value of marijuana stocks. This report shows how marijuana stocks are...Marijuana Analysis·14 Comments·
MedReleaf Up For Auction: Is the CEO Sending a Message to Investors? Scott Willis·May 2, 2018MedReleaf (TSX: LEAF) is being shopped around for sale, particularly to Aurora Cannabis (TSX: ACB). Find out reasons...Marijuana Analysis·2 Comments·
